It might be speculation that the increased production of microbial SCFAs may help ameliorate the reduced effect of incretin, which is often evident in T2DM patients, but further studies are needed to understand this process in more detail [57]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.